Status:
COMPLETED
Effect of an Artificial Pancreas in Patients Undergoing Hepatic Resection
Lead Sponsor:
Kochi University
Conditions:
Liver Diseases
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This study evaluated that strict control of perioperative blood glucose following hepatic resection by using an artificial pancreas would improve postoperative surgical site infection.
Detailed Description
This study recruited 70 patients undergoing elective hepatic resection for liver diseases. Perioperative blood glucose concentration was continuously monitored using an artificial pancreas system. We ...
Eligibility Criteria
Inclusion
- This study recruited 70 patients undergoing elective hepatic resection for liver diseases. Perioperative blood glucose concentration was continuously monitored using an artificial pancreas system.
Exclusion
- weight loss greater than 10% during the previous 6 months, signs of distant metastasis, and respiratory, renal, or heart disease
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00659698
Start Date
April 1 2007
End Date
April 1 2008
Last Update
April 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kochi Medical School
Nankoku, Kochi, Japan, 783-8505